Proprotein convertase subtilisin/kexin type 9 as a drug target for abdominal aortic aneurysm
{{output}}
Purpose of review: There are no current drug therapies to limit abdominal aortic aneurysm (AAA) growth. This review summarizes evidence suggesting that inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9) may be a dru... ...
